{"id":"W4407749356","doi":"10.1161/jaha.124.038656","title":"Cardiovascular Outcomes With Icosapent Ethyl by Baseline Low‐Density Lipoprotein Cholesterol: A Secondary Analysis of the REDUCE‐IT Randomized Trial","year":2025,"lang":"en","type":"article","venue":"Journal of the American Heart Association","topic":"Fatty Acid Research and Health","field":"Nursing","cited_by":15,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"National Heart, Lung, and Blood Institute; St. Jude Medical; Genentech; Idorsia Pharmaceuticals; Assistance publique-Hôpitaux de Paris; Duke Clinical Research Institute; Eisai; Pfizer; Moderna; Medicines Company; AstraZeneca; Amarin Corporation; Ironwood Pharmaceuticals, Incorporated; National Institutes of Health; Regeneron Pharmaceuticals; American Diabetes Association; Boston Scientific Corporation; Amryt Pharma; Esperion Therapeutics; Alnylam Pharmaceuticals; Belvoir Media Group; Amarin Pharma; Novo Nordisk; MyoKardia; Daiichi Sankyo Europe; Abbott Diagnostics; Servier; Gilead Sciences; Bristol-Myers Squibb; Cleveland Clinic; Brigham and Women's Hospital; HLS Therapeutics; GlaxoSmithKline; CSL Behring; Eli Lilly and Company; Amgen; Sanofi; American Heart Association","keywords":"Medicine; Internal medicine; Hazard ratio; Myocardial infarction; Placebo; Post-hoc analysis; Unstable angina; Clinical endpoint; Randomized controlled trial; Statin; Gastroenterology; Cardiology; Confidence interval","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003920288,0.00275811,0.004500834,0.0006415301,0.0003573496,0.001430178,0.0007464898,0.001218765,0.006121861],"category_scores_gemma":[0.004252615,0.0005470933,0.004627814,0.0007126029,0.001029755,0.000799266,0.0007171076,0.002710294,0.0006812055],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006354104,"about_ca_system_score_gemma":0.001112384,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001174116,"about_ca_topic_score_gemma":0.00154185,"domain_scores_codex":[0.9969886,0.001981364,0.0001921841,0.0003451095,0.0001895238,0.0003032302],"domain_scores_gemma":[0.9975957,0.0007401223,0.0007957311,0.0002957972,0.0002236722,0.0003489373],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.984924,0.001136821,0.001980947,0.001134542,0.00415035,0.00002832412,0.00002153729,0.0002699787,0.000648537,0.0001652967,0.001020011,0.00451956],"study_design_scores_gemma":[0.9601687,0.02095367,0.007427417,0.0001468968,0.008646645,0.0000449334,0.00003180117,0.0006063569,0.0005162487,0.0004263939,0.00100411,0.00002685846],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9641831,0.01319577,0.00178208,0.001180142,0.0009523697,0.005631868,0.00689263,0.0002362396,0.005945857],"genre_scores_gemma":[0.978515,0.003519445,0.001628829,0.001073153,0.001057317,0.006546242,0.005157771,0.00005066224,0.002451633],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006121861,"threshold_uncertainty_score":0.0207327,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0102023045317618,"score_gpt":0.3021811727743778,"score_spread":0.291978868242616,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}